Renin-angiotensin-system modulators and the incidence of atrial fibrillation following hospitalization for coronary artery disease
EP Europace, 05/16/2012
Singh JP et al. – Angiotensin converting enzyme inhibitor/angiotensin receptor blockers (ARB) therapy initiated within 1 month after hospital discharge is not associated with a reduction in the risk of new–onset atrial fibrillation (AF) after myocardial infarction or coronary revascularization.



